Patent details

EP3072906 Title: ANTIBODY FORMULATION

Basic Information

Publication number:
EP3072906
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP161626999
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTIBODY FORMULATION
French Title of Invention:
FORMULATION D'ANTICORPS
German Title of Invention:
ANTIKÖRPERFORMULIERUNG
SPC Number:

Dates

Filing date:
09/12/2009
Grant date:
08/09/2021
EP Publication Date:
28/09/2016
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
08/09/2021
EP B1 Publication Date:
08/09/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
09/12/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
01/09/2021
 
 

Name:
NOVARTIS AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:
MOMM, Joachim
Address:
Switzerland (CH)

2

Name:
WALLNY, Hans-Joachim
Address:
Switzerland (CH)

Priority

Priority Number:
08170884
Priority Date:
10/12/2008
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
C07K 16/24; A61K 39/395;

Publication

European Patent Bulletin

Issue number:
202136
Publication date:
08/09/2021
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
31/12/2025
Annual Fee Number:
17
Annual Fee Amount:
246 Euro
Expected Payer:
Last Annual Fee Payment Date:
28/11/2024
Last Annual Fee Paid Number:
16
Last Annual Fee Paid Amount:
230 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages